Company Data

Chemomab Therapeutics Ltd.

Ticker
CMMB
Current Price
$1.2 -1.64%
Market Cap
$22.6M
Price Target
Refer to Report
Volume
70.7K
52wk Range
$0.780101 - $2.55
Advanced Market Data

Overview

Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet need. The company’s lead candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy